Antibody discovery companies develop platforms and services for identifying antibodies used in therapeutics, diagnostics and life science research. Their technologies support candidate discovery, screening, optimisation and early development.
This category includes companies working on:
Browse 63 UK antibody discovery companies below.
Fibroblast immunology platform targeting cancer and inflammatory disease
Mestag Therapeutics is a clinical-stage biotechnology company developing first-in-class antibody therapies targeting activated fibroblasts to modulate immune responses in cancer…
Target discovery platform and antibody-based therapies for oncology
Oxford BioTherapeutics is an Oxford-based clinical-stage oncology company discovering and developing first-in-class antibody-based cancer therapies. Its proprietary platform…
Microgravity-based CDMO platform for crystallisation of biologic drugs
BioOrbit is a biotech developing a proprietary hardware platform for the crystallisation of protein-based biologic drugs in low Earth orbit. The company exploits the absence of…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein…
AI platform for in silico antibody discovery
Antiverse is a Cardiff-based company using machine learning to identify diverse and rare antibody candidates from next-generation sequencing data of naïve and immune repertoires.…
Recombinant antibody sequencing, engineering and manufacturing services
Absolute Antibody specialises in recombinant antibody technology, offering sequencing, engineering and production services alongside a catalogue of recombinant antibodies and Fc…
Antibody engineering platform improving solid tumour drug penetration
Creasallis is a Cambridge-based biotechnology company developing engineering solutions to improve the efficacy of antibody-based cancer therapies. Its patented technology modifies…
T cell-engaging multispecific antibody fragments for solid tumours
Crescendo Biologics is a clinical-stage biopharmaceutical company developing multispecific therapeutics based on fully human single-domain antibody fragments engineered for…
Custom recombinant antibody and protein development services
Scotia Biologics is a contract research organisation specialising in custom antibody and recombinant protein development for biomedical researchers and diagnostic developers.…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham…
Isoform-specific antibody therapeutics for vascular disease
IsomAb is a biotechnology company developing isoform-specific antibody therapeutics for serious vascular diseases. Its lead programme, ISM-001, targets VEGF-A165b, an…
AI-driven antibody reagents and diagnostics for research and clinical use
Vertebrate Antibodies is a contract research organisation developing custom monoclonal antibodies, recombinant proteins, and AI-driven diagnostic products for research and…